Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.
作者信息
Harris Adam, Eswaran Shanti, Bosworth Brian, Gambarin-Gelwan Maya, Scherl Ellen J
出版信息
Gastroenterol Hepatol (N Y). 2007 Nov;3(11):875-7.
Abstract
摘要
相似文献
1
Mesalamine-induced Pneumonitis and Serum Sickness-like Reaction.
Gastroenterol Hepatol (N Y). 2007 Nov;3(11):875-7.
2
Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
J Clin Gastroenterol. 1997 Jan;24(1):34-6. doi: 10.1097/00004836-199701000-00007.
3
[Mesalamine-induced hypersensitivity pneumonitis].
Harefuah. 1999 Jul;137(1-2):28-30, 87, 86.
4
Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.
Mt Sinai J Med. 2001 Nov;68(6):389-95.
5
Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.
Mt Sinai J Med. 2001 Nov;68(6):384-8.
6
Mesalamine-induced pneumonitis during therapy for chronic inflammatory bowel disease: a pediatric case report.
J Pediatr Gastroenterol Nutr. 2005 Oct;41(4):479-82. doi: 10.1097/01.mpg.0000173601.31647.84.
7
Mesalamine-induced lung toxicity.
Am J Gastroenterol. 1996 May;91(5):1039-40.
8
Interstitial pneumonitis due to mesalamine.
Ann Pharmacother. 1997 Apr;31(4):499. doi: 10.1177/106002809703100421.
9
Mesalamine-induced lung injury in a patient with ulcerative colitis and a confounding autoimmune background: a case report.
Mt Sinai J Med. 2005 Mar;72(2):136-40.
10
A rapid desensitization protocol in a case of drotaverine-induced serum sickness-like reaction in a pregnant woman: A case report.
Exp Ther Med. 2019 Dec;18(6):5105-5107. doi: 10.3892/etm.2019.8170. Epub 2019 Nov 7.
引用本文的文献
1
Nonasthmatic eosinophilic bronchitis in an ulcerative colitis patient - a putative adverse reaction to mesalazine: A case report and review of literature.
World J Clin Cases. 2020 Sep 26;8(18):4162-4168. doi: 10.12998/wjcc.v8.i18.4162.
2
Mild cutaneous reactions to drugs.
Acta Biomed. 2019 Jan 28;90(3-S):36-43. doi: 10.23750/abm.v90i3-S.8159.
3
Cutaneous drug reactions in children: an update.
Paediatr Drugs. 2013 Dec;15(6):493-503. doi: 10.1007/s40272-013-0039-z.
4
Is mesalamine safe?
Gastroenterol Hepatol (N Y). 2007 Nov;3(11):878-9.
本文引用的文献
1
Once-daily, high-concentration MMX mesalamine in active ulcerative colitis.
Gastroenterology. 2007 Jan;132(1):66-75; quiz 432-3. doi: 10.1053/j.gastro.2006.10.011. Epub 2006 Oct 12.
2
Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
Clin Gastroenterol Hepatol. 2007 Jan;5(1):95-102. doi: 10.1016/j.cgh.2006.10.025.
3
Extraintestinal manifestations in inflammatory bowel disease.
World J Gastroenterol. 2005 Dec 14;11(46):7227-36. doi: 10.3748/wjg.v11.i46.7227.
4
Mesalamine-related lung disease: clinical, radiographic, and pathologic manifestations.
Inflamm Bowel Dis. 2003 Sep;9(5):308-15. doi: 10.1097/00054725-200309000-00004.
5
Sulphasalazine and mesalazine: serious adverse reactions re-evaluated on the basis of suspected adverse reaction reports to the Committee on Safety of Medicines.
Gut. 2002 Oct;51(4):536-9. doi: 10.1136/gut.51.4.536.
6
Inflammatory bowel disease.
N Engl J Med. 2002 Aug 8;347(6):417-29. doi: 10.1056/NEJMra020831.
7
Oral desensitization to 5-ASA.
Allergy. 2002 Apr;57(4):371-2. doi: 10.1034/j.1398-9995.2001.1n3420.x.
8
Alterations in pulmonary function in inflammatory bowel disease are frequent and persist during remission.
Am J Gastroenterol. 2002 Feb;97(2):377-81. doi: 10.1111/j.1572-0241.2002.05473.x.
9
Can a drug-induced pulmonary hypersensitivity reaction be dose-dependent? A case with mesalamine.
Mt Sinai J Med. 2001 Nov;68(6):389-95.
10
Bronchiolitis obliterans in a patient with ulcerative colitis receiving mesalamine.
Mt Sinai J Med. 2001 Nov;68(6):384-8.
Zotero 插件